Ghost Tree Capital, LLC Aptevo Therapeutics Inc. Transaction History

Ghost Tree Capital, LLC

  • $267 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 11, 2021
SELL
$21.85 - $30.0 $1.09 Million - $1.5 Million
-50,000 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
$6.21 - $48.36 $310,500 - $2.42 Million
50,000 New
50,000 $1.83 Million

About Aptevo Therapeutics Inc.

APVO Quotes by TradingView
  • Ticker APVO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 5,090,640
  • Market Cap $1.07M
  • Description
  • Aptevo Therapeutics Inc., a clinical-stage biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States. Its lead clinical candidate is APVO436, a bispecific T-cell engaging antibody candidate that is in Phase 1b clinical trial for acute myelogenous leukemia and myelo...
More about APVO
Track This Portfolio

Track Ghost Tree Capital, LLC Portfolio

Follow Ghost Tree Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ghost Tree Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ghost Tree Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email